Phase II study of second line chemotherapy with carboplatin and paclitaxel for metastatic melanoma
Phase 2
Recruiting
- Conditions
- melanoma
- Registration Number
- JPRN-UMIN000003260
- Lead Sponsor
- Division of Skin Oncology, Comprehensive cancer center, Saitama medical university International medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have brain metastases which are not controlled by surgery or radiotherapy 2. Patients without myelosuppresion-Neutrophilic leukocyte<1,500/mm3, PLT<100,000/mm3 3. Patients with severe disorders in heart (NYHA Grade 2 or more), lung, liver, kidney or brain. 4. Patients who are pregnant or nursing 5. Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of combination therapy with carboplatin and paclitaxel in patients with metastatic melanoma
- Secondary Outcome Measures
Name Time Method